Cargando…
Metabolomics analysis of salvage chemotherapy on refractory acute myeloid leukemia patients
Acute myeloid leukemia (AML) is a group of hematological malignancies causing high mortality around the world. However, the treatment of AML is still one of the most formidable challenges. In this study, we employed a well-established global metabolic profiling platform, which combined ultra-perform...
Autores principales: | Zheng, Zhi, Liu, Pingyi, Xu, Liting, Peng, Zhiqiang, Zhang, Yayue, Chen, Xinyi, Hou, Li, Cui, Wenhao, Tou, Fangfang, Rao, Jun, Fan, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079900/ https://www.ncbi.nlm.nih.gov/pubmed/35540790 http://dx.doi.org/10.1039/c7ra13298k |
Ejemplares similares
-
Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
por: Popescu, Bogdan, et al.
Publicado: (2019) -
Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy
por: Mühleck, Regina, et al.
Publicado: (2021) -
Molecular Characterization of Advanced Colorectal Cancer Using Serum Proteomics and Metabolomics
por: Rao, Jun, et al.
Publicado: (2021) -
Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia
por: Cummins, K D, et al.
Publicado: (2014) -
Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia
por: Cummins, K D, et al.
Publicado: (2014)